![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 32, 22821-22829, August 6, 1999
From the Department of Molecular Biology, Lewis Thomas Laboratory,
Princeton University, Princeton, New Jersey 08540-1014
The NM23 gene family in humans
is implicated in differentiation and cancer, but the biochemical
mechanisms are unknown. Most NM23 proteins have phosphotransferase
(nucleoside diphosphate kinase) activity, and the second human
isoform, NM23-H2, also binds to a nuclease-hypersensitive
c-MYC promoter element through which it activates
c-MYC transcription. It is shown here that this DNA binding
can result in double-stranded breaks. The DNA breaks occur within
repeated sequence elements in the linear nuclease-hypersensitive duplex
and leave staggered ends with 5-nucleotide-long 3'-extensions. The
enzyme also cleaves supercoiled plasmid DNA to yield nicked circular
and unit length linear products. The cleavage reaction requires only
NM23-H2, DNA, Mg2+, and buffer, occurs in the absence of
denaturing conditions, and can be reversed by EDTA. The cleaved DNA
strands have free 3'-OH groups, and protein is attached to the
5'-phosphoryl ends. Transfer of 32P radioactivity from DNA
to NM23-H2 has been observed, and a covalent polypeptide-DNA complex
has been isolated and identified by Western blotting as NM23-H2. Since
covalent protein-DNA complexes are known to serve the role of breaking
and rejoining DNA strands, the present findings suggest that NM23-H2 is
involved in DNA structural transactions necessary for the activity of
the c-MYC promoter.
The NM23 gene was originally identified as a potential
metastasis suppressor gene by virtue of its reduced expression in
highly metastatic melanoma and breast carcinoma cells (1-3). It was found subsequently that NM23 expression varies in a wide
spectrum of human cancers and that up-regulation of NM23 may
play a role in the pathogenesis of tumors (4-6). The gene family is
large and highly conserved (7, 8) and, in a wide variety of animal species, functions in normal cellular proliferation and development (3,
9, 10). Of the five distinct human genes identified to date (2, 8,
11-13), four are implicated in differentiation control (12-16), and
two, NM23-H1 and H2, are also involved
in cancer (2-6). NM23-H1 and H2 are
88% identical in sequence and map 4 kb1 apart on chromosome
17q21-22 near the BRCA1 locus (17).
NM23-H1 and -H2 each encode 152 amino acid peptides that are
the subunits of the A and B nucleoside diphosphate kinases (NDP kinase;
see Ref. 18), respectively. NDP kinases are phosphotransferases that
reversibly catalyze phosphoryl group transfers between nucleoside diphosphates and nucleoside triphosphates, exhibiting little
specificity toward either the donor or the acceptor nucleotides. The
intermediate in the reaction is a highly conserved histidine that
becomes autocatalytically phosphorylated (see Ref. 19, for review).
Crystallographic evidence indicates that NM23/NDP kinase is a hexamer
of six identically folded subunits, enclosing a large (25 Å) central
cavity. The hexamer has dihedral 3-fold (D3) symmetry and can be viewed
as a dimer of trimers or a trimer of dimers, with the dimers exhibiting 2-fold symmetry (20, 21).
NM23-H2/NDP kinase B was identified in our laboratory as a DNA-binding
protein and transcriptional activator of the human c-MYC
gene, known previously as PuF (22, 23). NM23-H2/PuF recognizes a
nuclease-hypersensitive transcriptional regulatory element in the human
c-MYC promoter termed NHE, through which it activates
c-MYC transcription in vitro and in cell
transfection assays (22-24). In vivo footprinting
experiments showed that NM23-H2/PuF also binds to the NHE in
vivo which correlates with the differentiation of promyelocytic
HL60 cells (25), and with the oncogenic activation of the
c-MYC gene in Burkitt lymphoma (16). The NHE
(nuclease-hypersensitive element)
lies between NM23-H2 does not resemble conventional transcription factors.
Mutational analysis (26) has suggested an unusual, combinatorial DNA-binding surface with dyad symmetry, a surface that is represented three times in the hexamer. Moreover, stoichiometric amounts of protein
are needed to achieve significant DNA binding activity (23, 26). The
present paper extends these observations by showing that NM23-H2
binding to the c-MYC NHE sequence can result in
double-stranded DNA breaks. The cleaving of DNA is reversible, and a
covalent protein-DNA complex is formed. These properties implicate
NM23-H2 in structural transactions of DNA and are consistent with our
earlier proposal (23) that PuF/NM23-H2 regulates human c-MYC
activity by interacting with structural elements of the promoter.
Purification of NM23 Proteins
NM23-H2 was purified from overexpressing bacteria by ammonium
sulfate fractionation and hydroxyapatite chromatography as described (23), with the addition of an ion exchange chromatography step prior to
hydroxyapatite fractionation. The DEAE column retains the DNA and most
bacterial proteins, including bacterial NDP kinase, whereas NM23-H2 is
eluted with 50 mM Tris buffer, pH 8 (19). Protein
preparations were apparently homogeneous as assessed by SDS-PAGE and
hexameric as determined by size exclusion chromatography (26). Affinity
purified NM23-H2 was prepared by applying the 60-90% ammonium sulfate
fraction to a Blue Sepharose (19) or Reactive Yellow agarose, column
(27) and subsequent elution with a NaCl gradient. NM23-H1 was purified
by ammonium sulfate fractionation (60-90% saturation), elution from
DEAE-cellulose with a NaCl gradient, followed by hydroxyapatite and
size exclusion chromatography (23, 26).
Preparation and Radiolabeling of DNAs
Double-stranded oligonucleotides were prepared by mixing
equimolar concentrations of each DNA strand in 10 mM Tris
buffer, pH 7.0, 200 mM NaCl and by heating to 95 °C and
slow cooling. After 5'-end labeling with [ DNA Binding and Gel Mobility Shift Analysis
Ten microliter reactions were assembled in Reaction Buffer (50 mM Tris-HCl, pH 7.9, 0.5 mM dithiothreitol, and
50 µg/ml bovine serum albumin). MgCl2, KCl, EDTA,
protease K, and ATP were added as specified in the figure legends.
Radiolabeled DNA and NM23-H2 in storage buffer (20 mM
Hepes, pH 7.9, 5 mM MgCl2, 0.1 mM
EDTA, 0.1 M KCl, 1 mM dithiothreitol, 20%
glycerol, and protease inhibitors; see Ref. 22) were added last, and
the reactions were incubated for 15 min at room temperature. To
separate the protein-DNA complexes, the reactions were loaded onto 5%
native polyacrylamide gels and electrophoresed in 0.5× TBE buffer (45 mM Tris borate, pH 8.3, 1.25 mM EDTA) at room
temperature for 30 min at 100 V. Gels were vacuum-dried and exposed
onto XAR (Eastman Kodak Co.) films.
Mapping of the DNA Cleavage Sites
Reactions were prepared in Reaction Buffer as for mobility shift
analysis, with the addition of 1 mM MgCl2 and
50 mM KCl. The reactions were incubated for 30 min at
30 °C, terminated with SDS (2% final concentration), and treated
with 200 µg/ml proteinase K (Roche Molecular Biochemicals) at
55 °C for 30 min. Samples were extracted with a 1:1 mixture of
phenol and chloroform, concentrated by ethanol precipitation, and
resuspended in 5 µl of 80% formamide, 3 mM EDTA, and
tracking dyes. The dissolved DNAs were heated for 5 min at 90 °C and
analyzed on 16% sequencing gels. Sequencing ladders were prepared
according to standard protocol (29).
Plasmid Cleavage Assays
Supercoiled pUC19 plasmid (2.6 kb) containing the 57-bp c-Myc
NHE insert was incubated with NM23-H2 in Reaction Buffer with the
various cofactors as specified in the figure legends. After 30 min at
20 °C the reactions were terminated with 1% SDS, 10 mM
EDTA, and proteinase K treatment (200 µg/ml) for 30 min at 55 °C.
Control topoisomerase I (Life Technologies, Inc.) reactions were
carried out under identical conditions. Following addition of a gel
loading dye (5% glycerol, 5 mM EDTA, 0.02% bromphenol blue), samples were resolved on 1% agarose gels in TAE buffer (40 mM Tris sodium acetate, 2 mM EDTA). The gels
were stained with 0.5 µg/ml ethidium bromide for 30 min, destained in
water, and photographed under short wave UV illumination.
Analysis of Covalent Protein-DNA Complexes
Transfer of DNA 32P Label to NM23-H2--
Uniformly
labeled plasmid (25 ng, specific activity 1-2 × 108
cpm/µg) was mixed with an equal amount of unlabeled plasmid and with
4 µg of NM23-H2 and incubated in Reaction Buffer containing 40 mM KCl and 1.5 mM MgCl2 for 30 min
at room temperature. The reaction was terminated by heating for 10 min
at 90 °C, and the bulk DNA was exhaustively digested with 30 units
of DNase I (Roche Molecular Biochemicals) and 145 units of exonuclease
III (Amersham Pharmacia Biotech) overnight at 37 °C; this treatment
was repeated for an additional 6 h. One sample was further treated
for 60 min with 500 µg/ml proteinase K. The reaction mixtures were
precipitated with 10% trichloroacetic acid by incubation on ice for 30 min. The centrifuged pellets were rinsed with trichloroacetic acid and
ethanol, dried, and resuspended in SDS-PAGE sample buffer. After
boiling for 5 min the samples were resolved on 4-15% SDS-PAGE gels.
The gels were stained with Coomassie Brilliant Blue for 1 h,
destained overnight in 20% acetic acid, 10% methanol, and vacuum-dried prior to photography and exposure to x-ray film. Molecular
mass standards were purchased from Life Technologies, Inc.
Western Analysis of Protein-DNA Adducts Isolated from Mobility
Shift Gels--
Reactions of NM23-H2 with 105-bp DNA fragments (26)
5'-end-labeled at both ends with [ Determination of the Polarity of the Protein-DNA
Linkage--
Uniquely end-labeled 57-bp DNA fragments were incubated
in standard reactions with varying amounts of KCl, followed by the addition of SDS, EDTA, and, as indicated, proteinase K treatment. The
reactions were diluted 2-fold with sequencing gel-loading buffer,
heated for 5 min at 90 °C, and loaded onto 5 or 8% sequencing gels.
NM23-H2 Cleaves Linear Duplex DNA--
NM23-H2 was previously
identified in our laboratory as a DNA-binding protein with affinity for
a polypurine/polypyrimidine sequence of the human c-MYC
promoter, termed NHE (see Ref. 23; Fig.
1). In the context of these studies we
noted that purified NM23-H2 preparations also cleaved the substrate
DNA, provided it contained the NHE sequence (Fig.
2, lanes 2 and 3).
Unrelated DNA or oligonucleotides that did not bind NM23-H2 (23) were not cleaved by the enzyme (Fig. 2, lanes 4 and
5), indicating that the cleavage of DNA, like the DNA
binding, is sequence-dependent. NM23-H2 mutant proteins
known to be defective in DNA binding (26) showed significantly reduced
cleaving activity in comparison with wild type (Fig. 2, lanes
6 versus 7). Additional experiments indicated that NM23
proteins purified by affinity chromatography through Blue Sepharose
(19) or Reactive Yellow (27) also contained DNA binding and cleaving
activity.2 These observations
suggested that the cleavage of DNA by NM23-H2 depends on an intrinsic
component of the wild type protein and that the cleavage is
functionally related to the DNA binding activity.
Experiments examining the role of metal ions on DNA cleavage indicated
that cleavage was stimulated by Mg2+ ions (Fig.
3A), whereas KCl was
inhibitory (Fig. 3B). When EDTA was included in the
reaction, the cleavage was virtually abolished (Fig. 3C,
lanes 3 versus 2 and 8 versus 7). However, when
EDTA was added at the end of the cleavage reaction followed by
proteinase K treatment, the cleavages were restored almost completely
in both the uniquely end-labeled 3'- and 5'-end DNA fragments (Fig. 3C, lanes 4 versus 2 and 9 versus
7). These results demonstrated that 1) DNA breaks occur in
both strands and 2) that the breaks can be restored upon removal of
divalent cations by EDTA treatment; the latter suggests that the
cleavage reaction is mediated by a covalent protein-DNA complex.
The high energy cofactor ATP was not required for the cleaving
activity; in fact, 1 mM ATP was inhibitory (Fig.
3C, lanes 5 versus 2 and 10 versus
7). Because the inhibition depended, to some extent, on the
order of addition of ATP and MgCl2, it was probably due in
part to tying up Mg2+ ions. Since KCl or EDTA did not
significantly affect the DNA binding, it seems likely that the binding
and cleavage of DNA are separate steps and that the binding is a
prerequisite for the cleaving activity.
Mapping of the Cleavage Sites on DNA Induced by NM23-H2--
To
confirm that the breaks occur in both DNA strands and to determine the
size of the newly produced fragments, the products of the cleavage
reaction were analyzed on sequencing gels (29). The use of denaturing
gels allows the visualization of a break produced in a single strand
that is uniquely end-labeled. With the 57-bp c-MYC DNA
fragment labeled at the EcoRI restriction site, we located a
strong cleavage site at 12 nucleotides from the 3'-end on the top
strand (Fig. 4A, lane
6). Several additional but less prominent cleavages were also
noted in the top strand, all appearing between the first and second
cytosine residues, counting from the 3'-end, of the CTCCCCA directly
repeated sequence (indicated by small arrows on the
right side panel). A prominent break also occurred in the
5'-end-labeled bottom strand between the fifth and sixth guanines in
the first repeat element, at 17 nucleotides from the 5'-end (Fig.
4A, lane 3). This indicated that the fragment that was
cleaved off at the 5'-end was longer, by 5 nucleotides, than the
fragment released from the 3'-end. Of several minor cleavages on the
bottom strand, at least one other occurred between the fifth and sixth
position in the next repeat element (lane 3, marked by a
small arrow on the right side panel). These and
several other independent experiments established the following: 1) DNA
is cleaved in both strands; 2) the cleaved DNA ends are staggered with
single-stranded 3' termini; and 3) the strand breaks occur ~5 bp
apart. A schematic representation of these findings is shown in Fig.
4B. Chemical sequencing (29) of gel-purified DNA cleavage
products confirmed the major cleavage sites on both
strands.3
Cleavage of Negatively Supercoiled DNA by NM23-H2--
Because the
natural DNA-binding substrate of NM23-H2 is a potentially distorted DNA
region that may be under superhelical stress, we considered the
possibility that NM23 may have DNA topoisomerase-like activity, binding
and cleaving this structure in order to relax it. To test for such an
activity, NM23-H2 protein was incubated with supercoiled pUC19 plasmid
DNA containing the 57-bp c-MYC, NHE sequence; the reaction
was terminated with detergent and the protein removed by proteinase K
treatment, and the products were monitored by horizontal agarose gel
electrophoresis. Under standard DNA-binding conditions, i.e.
in the presence of 120 mM KCl and saturating
(stoichiometric) amounts of protein (greater than a 1:2 hexamer to
plasmid ratio), NM23-H2 had no relaxation activity and yielded products
that comigrated with nicked (open circular) and cleaved unit length
(linear) plasmids (Fig. 5A).
In most cases, however, when the presumed "open circular" plasmids
were gel-purified and subjected to a second round of electrophoresis,
more than half of these structures comigrated with the linear products, indicating that the open circular products are a mixed population. Nonetheless, the conversion of negatively supercoiled plasmids to
nicked circular DNA suggests the production of single-stranded breaks,
whereas the presence of linear molecules signify double-stranded cleavage. The structure of these plasmid products, and the relationship of the nicking and cleaving, remain to be addressed. It should be noted
here that the cleavage of plasmid DNA, like that of linear DNA
fragments, occurs in the absence of detergent, although SDS can
liberate additional fragments from one DNA end (see Fig.
7B). Therefore, SDS, EDTA, and proteinase K were
routinely added at the end to terminate
the reactions and remove NM23.
Plasmid cleavage, like the cleavage of linear DNA, was also inhibited
by high (>200 mM) KCl concentrations. In the absence of
KCl, however, and with limiting amounts of protein (less than 1:2 NM23
hexamer to plasmid ratio), NM23-H2 relaxed supercoiled plasmids in a
stepwise manner, although the extent of the relaxation appeared to be
limited to superhelical densities in between the supercoiled and linear
population.4 Additional
experiments will be needed to understand this activity.
Cleavage of plasmid DNA was inhibited by the addition of EDTA at the
start of the reaction (Fig. 5B, lane 4 versus lane 3), indicating a requirement for
divalent cations. When EDTA was added at the end of the reaction
followed by proteinase K treatment, the linear plasmid band
disappeared, and most, but not all, of the nicked plasmids were
reverted to supercoiled forms (lane 5). The presence of 1 mM ATP in the reaction inhibited the cleaving activity,
although it allowed some nicking to take place (lane 6).
These findings suggest that the cleavage of plasmid DNA is due to the
same activity of NM23-H2 as that which cleaved linear DNA and that the
cleavage of plasmid DNA is also a reversible reaction. When NM23-H2 was
incubated with the monoclonal antibody 3E4 known to inhibit DNA binding
(26), the cleaving and nicking activities were diminished, and the
plasmid showed partial relaxation (lane 7). This interesting
result implies that there may exist more than one region on the protein
for DNA interaction. The DNA-binding defective mutant K135H was also
defective in the cleaving activity (lane 8), whereas the
related NM23-H1 protein behaved similarly to the wild type NM23-H2
(lane 9). Apparently, NM23-H1 either recognizes negatively
supercoiled NHE DNA better than linear NHE DNA (to which it binds
poorly; see Ref, 26) or it recognizes a different DNA sequence embedded
in the pUC19 plasmid. Indeed, DNA binding by NM23-H1 to an upstream
sequence in the platelet-derived growth factor promoter has recently
been identified.5
Several novel plasmid bands were also produced by the reaction of NM23
with DNA, as indicated by asterisks on the side panels in
Fig. 5, A and B. These new bands move more slowly
and are not present in the reactions with DNA only (lanes
1). Since the mobilities of these plasmid forms are not affected
by proteinase K treatment, they are unlikely to be caused by
retardation through protein binding and may thus be catenated multimers
or other products of recombination. Conditions are under investigation
that will permit higher frequencies of such NM23-induced plasmid multimerizations.
Transfer of Radioactivity from Uniformly 32P-Labeled
Plasmid DNA to NM23-H2--
The reversibility of DNA cleavage by
NM23-H2 implied that a covalent protein-DNA intermediate is involved in
these reactions. Such covalent intermediates are common energy sources
for strand breakage and reunion by DNA topoisomerases and site-specific
recombinases (30-35). To determine if NM23-H2 indeed becomes
covalently linked to DNA during the cleavage reaction, the enzyme was
reacted with uniformly 32P-labeled plasmid DNA,
heat-denatured, the bound DNA hydrolyzed, and the products analyzed on
denaturing SDS-PAGE gels. The Coomassie Brilliant Blue stained gel is
shown on the left panel of Fig. 6A. Autoradiography of the
same gel indicates that transfer of radioactive phosphate to the
protein has taken place, as radiolabel is present only in the NM23-H2
17-kDa peptide (Fig. 6A, lane 3, right-hand
panel). In control experiments without NM23, nuclease treatment of the plasmid completely eliminated the acid-precipitable radiolabel (lane 2), whereas proteinase K treatment of the
complex digested NM23-H2 and caused the radiolabel to become
acid-soluble (lane 4). This experiment indicates that the
linkage between NM23-H2 and radiolabeled DNA is likely to be covalent.
Lane 1 shows the pure NM23-H2 protein without any DNA and
enzyme treatment, except that it was autophosphorylated with
[ Western Analysis of NM23-H2-linear DNA Complexes Purified from
Mobility Shift Gels--
To probe the covalent interaction further, we
examined the stability of the linkage between NM23-H2 and radiolabeled
DNA in the complexes resolved on native polyacrylamide gels
(e.g. Figs. 2 and 3). The shifted complexes were excised
from the gel, purified, and subjected to electrophoresis in the second
dimension on denaturing SDS-PAGE gels. Autoradiography of the SDS-PAGE
gel identified the labeled DNA component (Fig. 6B, left
panel), and subsequent Western blotting identified the NM23-H2
peptide (Fig. 6B, right panel). Clearly, NM23 and DNA
purified from the complex have the same mobility on denaturing SDS-PAGE
gels (~26 kDa). This mobility appears to be in between that of
monomeric NM23-H2 (17 kDa) that has not been exposed to DNA treatment
(lanes 3) and dimeric NM23-H2 (~34 kDa), produced by
chemical cross-linking (lanes 2 and 4; see Ref.
26). These results confirm that the polypeptide in the purified
protein-DNA complex is NM23-H2 covalently bound to the radiolabeled DNA fragment.
NM23-H2 Is Attached to the 5' Terminus of the Broken DNA
Strand--
To determine which of the DNA termini at the cleavage site
formed the covalent linkage, we analyzed the effect of protein association, with and without proteinase K treatment, on the
electrophoretic mobility under denaturing conditions of uniquely
end-labeled DNA fragments. Such experiments are used commonly to
demonstrate the polarity of the covalently linked DNA strand. However,
interpretation of the data with NM23 may be complicated by the fact
that significant DNA breakage already occurs in the absence of added
detergent, whereas topoisomerases require detergent or drugs to effect
DNA cleavage. Therefore, these experiments were performed under
conditions where DNA cleavage is limited (120 mM KCl), as
well as under conditions where cleavage takes place (30 mM
KCl), and with both short (57 bp) and long (2.6 kb) uniquely
end-labeled DNA fragments. In the absence of cleavage, a more slowly
migrating shifted band was observed with the 3'-end-labeled 57-bp DNA
fragment that was erased by proteinase K treatment (Fig.
7A, lane 5 versus 6). Because covalent protein-DNA complexes at a given
time comprise only about 5% of the total enzyme present, they are
difficult to capture even under "ordinary" circumstances (30-32).
Nonetheless, the amount of retarded radiolabel in lane 5 appears to be in a similar order of magnitude. By using identical
conditions, there is no shifted band with the 5'-end-labeled DNA
fragment (lanes 2 and 3). In the case where
substantial cleavage occurs, again there is no significant change upon
proteinase K treatment in the migration pattern of the cleaved DNA
labeled at its 5'-end (Fig. 7B, lanes 2 and
3). In contrast, with the 3'-end-labeled DNA, proteinase K
digestion liberated shorter DNA fragments (lanes 5 versus 6). The results of these and several other
independent experiments all indicate that there is no NM23 protein
trapped by SDS at the 3'-end but that there is protein on the 5'-end,
designating the 5'-end of the cleaved DNA strand as the site of
covalent NM23-H2 protein-DNA attachment.
Finally, it can be shown that NM23-H2-cleaved DNA ends have free
3'-hydroxyl groups, since they could be labeled to a high specific
activity by terminal deoxynucleotidyltransferase and [ Numerous observations in the past have caused speculation that the
NM23/NDP kinase family of proteins may perform a more sophisticated role in cell physiology than merely catalysis of nonspecific phosphoryl group transfer (3, 19, 38). Buttressing these ideas was our discovery
that NM23-H2/NDP kinase-B is a DNA-binding and transcriptionally active
protein (23, 39). The present study demonstrates that human NM23-H2
indeed has additional activities and that these are related to DNA
binding. It is shown here that NM23-H2 cleaves the c-MYC NHE
promoter element, its natural duplex DNA substrate, site-specifically
and within the directly repeated 5'-CCTCCCCA motifs. These cleavages
have staggered, 5-nucleotide-long 3'-overhangs. The enzyme also cleaves
negatively supercoiled plasmid DNA containing the NHE element, yielding
linear, unit length fragments and nicked circular products, and, at a
low frequency, generating plasmid multimers.
DNA cleavage is stimulated by divalent cations and is inhibited by
EDTA, salt, and ATP. The cleaving activity requires stoichiometric rather than catalytic amounts of NM23, suggesting that two or more
protein molecules are necessary to effect a double-stranded DNA break.
Cleavage is not dependent on the addition of detergent, proteinase K,
or drugs, unlike the breaks induced by topoisomerases, suggesting that
NM23 is not holding the DNA strands together during the reaction.
However, the cleavage reaction can be reversed by EDTA, indicating that
NM23-H2 has the ability to reseal the broken DNA strands.
A reversible DNA cleavage reaction requires breakage and religation of
DNA strands through a covalent enzyme-DNA complex (31, 32, 40, 41), and
these data suggest that NM23-H2 is capable of forming such covalent
bonds. This was confirmed by the following experiments. First, transfer
of 32P radiolabel from DNA to protein was detected. Second,
the retarded complex in mobility shift gels contained NM23-H2,
identified by antibody, bound to DNA in a covalent complex. Third,
linkage to the 5'-end and not to the 3'-end of the cleaved DNA strand
of the SDS-trapped protein was demonstrated, leaving the 3'-hydroxyl groups free. All of these findings are consistent with the conclusion that NM23-H2 can break and reseal the phosphodiester bond of DNA through a covalent enzyme-DNA complex. Since covalent protein-DNA complexes are known to serve the role of breaking and rejoining DNA
strands, the present findings support our earlier proposal (23, 39)
that NM23-H2 is involved in modifying the structure of the promoter
necessary for the activity of the the c-MYC gene. We have
taken steps to confirm the covalent bond formation by identifing the
nucleotide and amino acid residues in the complex and by determining
the chemical nature of their linkage.
A combined set of criteria strongly suggests that the activities
described in this paper are not caused by a trace bacterial contaminant. First, DNA cleavage by the wild type protein is
independent of the enzyme purification procedure. Second, mutant
proteins deficient in DNA binding activity, which were purified by the same procedure as the wild type protein, were defective in the cleaving
activity. Third, NM23-H1, an acidic protein, also cleaves plasmid DNA,
although it is purified differently from NM23-H2 (which is basic; see
Ref. 19), and would, therefore, be expected to copurify with a
different set of contaminants. Most important, however, is the
observation that the broken DNA strands contained NM23-H2 polypeptides
in a covalently bound form, strongly suggesting that the properties of
NM23-H2 described in this paper are intrinsic and that the same
activity that breaks DNA is the one responsible for its resealing.
Although these data are still too preliminary to suggest a mode of
interaction of NM23 with DNA, the inhibition by ATP and the stimulation
by Mg2+ of DNA cleavage is interesting in light of the
inherent NDP kinase activity. NM23 binds ATP in its NDP kinase active
site, where ATP donates a phosphate to the autocatalytic histidine
(19). The active site of NDP kinase is shared during the catalytic
cycle both by the donor and the acceptor nucleotides, as well as by Mg2+, and Mg2+ greatly stimulates the turnover
rate of the phosphotransferase activity (42). Thus, the inhibition of
DNA cleavage by ATP suggests that, at least in part, ATP controls the
cleavage through the NDP kinase active site and that Mg2+
competes for the active site with ATP. In addition,, ATP may tie up
Mg2+ ions directly, and the phosphorylation of the
catalytic His-118 may also be inhibitory.
Enzymes that structurally modify DNA using a covalent protein-DNA
complex are DNA topoisomerases (31, 32, 40, 41), and "conservative"
site-specific recombinases (33-35). It is noteworthy that
topoisomerase II and site-specific recombinases also require stoichiometric amounts of protein for their DNA cleaving activities (32-35). In cleaving both DNA strands, NM23 resembles a type II-like topoisomerase activity, although a type I-like action is also a
possibility since these enzymes can also yield double-stranded breaks
opposite nicks in the other strand (32). Clearly, though, NM23-H2 is
not a typical DNA topoisomerase, for it does not seem to allow the
plasmid to remain a covalently closed circle throughout the relaxation
reaction. In terms of the chemistry of the cleavage site and the
unusual DNA-binding surface of the protein, NM23 resembles
resolvase-like recombination enzymes. A search in the data base,
however, failed to detect significant amino acid sequence homologies between NM23-H2, topoisomerases, and recombinases.
It is an interesting question as to whether the NDP kinase and the DNA
cleaving activities of NM23 are related to each other in
vivo. It has been generally assumed that NDP kinases are of paramount importance to cell survival. As highly efficient
phosphotransferases (the term "kinase" is a misnomer), they are
thought to function in maintaining critical intracellular nucleotide
concentrations, although the precise role of this activity in
metabolism has not been demonstrated. Interestingly, in the case of the
Drosophila NM23 protein AWD, it has been observed that
although the catalytic histidine is necessary, it is not sufficient for
AWD biological activity. This suggests that AWD/NM23 has another
activity that is distinct from its role in the NDP kinase catalytic
cycle, which also requires this histidine (38). One might suppose that
this "other" activity is related to the DNA transactions
demonstrated herein. Since covalent bond formation involves phosphoryl
group transfer from DNA to protein, the phosphotransferase (NDP kinase) active site of NM23-H2 may well be involved in this reaction. For
example, the conserved autocatalytic His-118 of NM23-H2 (18, 36) may
play the role of activating nearby potential nucleophiles (e.g. Tyr-52 or Ser-120), in a reaction similar to that used
by type I topoisomerases and Int recombinases (35, 43). Another possibility is, of course, that a functional relationship between the
NDP kinase and the DNA transactional properties of NM23 does not exist
and that the enzyme performs multiple and independent functions in DNA metabolism.
Chromatin structure is inextricably linked to transcription (32, 40).
Specific topological changes and chromatin rearrangements are known to
occur during different stages of both development and cancer and are
presumed to modulate stage-specific transcription (44). A progression
to the metastatic state in the case of human breast tumors, for
example, involves structural modifications in DNA that are considerably
different from the topological alterations associated with the
formation of primary tumors (45). However, enzymes that can carry out
such stage-specific topological changes in mammalian systems have not
been identified. The human NM23 family of proteins is a good candidate
for such a role, for there exist at least five isoforms that are
differentially expressed (see Introduction and Ref. 39) and that may
also form mixed oligomers in vivo (18). The ability of NM23
(so far restricted to NM23-H2 and H1), to specifically recognize
regulatory sequences in DNA and to specifically alter these sequences,
might well be brought into play for a particular gene and at a certain
step in the activation process. The nuclear localization of NM23-H2 in
several tissues, including breast cancer cells (46), and its
association with chromatin (47), have already been demonstrated.
As a key regulator of growth and differentiation and as a major factor
in oncogenesis, the c-MYC gene is a likely target for selective regulation by sequence-specific DNA rearrangements. The
c-MYC promoter, a natural substrate of NM23-H2, is comprised of a sequence (NHE), which is structurally distorted and may be inhibitory to transcription. This repression may be counteracted by
NM23-H2 through alterations or removal of the inhibitory sequence, converting the NHE into a more typical B conformation, thereby providing access of conventional transcription factors to the promoter.
The ability of NM23-H2 to alter the structure of the c-MYC
promoter is consistent with the observations that in tumors where
NM23 is overexpressed, alterations in the c-MYC
gene structure are common (4-6, 16, 48-50).
I thank P. Schedl, J. Stock, and J. Janin for
invaluable advice and discussions; J. Flint for support; T. Grebbe for
computer searches; and M. Feld for technical assistance.
*
This work was supported by National Institutes of
Health/National Cancer Institute Grant CA76496 (to E. H. P.) and by
NATO Collaborative Research Grant SA.5-2-05 CRG 94069 (held jointly with J. Janin, University of Paris-Sud).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
2
Molecular Biology Corelab students, Princeton
University, and E. H. Postel, unpublished results.
3
E. H. Postel, unpublished results.
4
E. H. Postel and M. Feld, unpublished results.
5
B. Liu, S. Zimmer, E. H. Postel, and D. Kaetzel, submitted for publication.
The abbreviations used are:
kb, kilobase pair;
PAGE, polyacrylamide gel electrophoresis;
bp, base pairs;
NDP, nucleoside diphosphate;
NHE, nuclease hypersensitive site.
Cleavage of DNA by Human NM23-H2/Nucleoside Diphosphate Kinase
Involves Formation of a Covalent Protein-DNA Complex*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
160 and
101 bp from the P1 transcription initiation
site of the c-MYC promoter and is comprised of a
polypurine/polypyrimidine sequence prone to form non-B DNA structures
and intermolecular triplexes (reviewed in Refs. 22 and 23). Embedded in
the NHE sequence is an assortment of directly repeated elements,
including three CCTCCCCA motifs and two CCCACCC PuF/NM23-H2-binding
sites (16, 22).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]ATP and
T4 polynucleotide kinase (Amersham Pharmacia Biotech), the
oligonucleotides were gel-purified by electroelution and
ethanol-precipitated. The 57-bp-long DNA substrate was obtained by
restriction of the pUC19myc plasmid with BamHI and
EcoRI restriction enzymes. This plasmid contains a 45-bp
c-MYC NHE sequence and seven additional bases at the 5'-end
and four on the 3'-end (Fig. 1), cloned into the unique
BamHI and EcoRI restriction sites of the pUC19
plasmid (gift of R. Durland). Uniquely end-labeled DNA fragments were obtained after EcoRI restriction cleavage by either 3'-end
labeling with T7 polymerase (Amersham Pharmacia Biotech),
[
-32P]dTTP, and [
-32P]dATP or by
5'-end labeling with polynucleotide kinase and
[
-32P]ATP. The end-labeled products were cleaved with
BamHI, and the resulting 57-bp fragments were gel-purified.
Radiolabeled nucleotides were purchased from NEN Life Science Products.
To end label the 3'-OH group, linear plasmid DNA produced by NM23-H2
cleavage was gel-purified and labeled with [
-32P]ddATP
(Amersham Pharmacia Biotech) and terminal
deoxynucleotidyltransferase (Promega). Uniformly radiolabeled pUC19myc
plasmid was prepared by nick translation using
[
-32P]dCTP and a commercial kit (Amersham Pharmacia
Biotech Quick Prime Kit) and by following the experimental protocol of
the supplier. Negatively supercoiled plasmids were prepared by the
alkali lysis procedure using a kit (Qiagen). Nicked circular plasmid
was prepared by DNase I (Roche Molecular Biochemicals) treatment (28)
and linear plasmid by BamHI restriction.
-32P]ATP (10:1
protein to DNA ratio) were first separated on native 5% acrylamide
gels. The radiolabeled protein-DNA complexes were excised and eluted
into buffer containing 50 mM Tris, pH 8, 0.1% SDS, 0.1 mM EDTA, 150 mM NaCl, and 0.1 mg/ml bovine
serum albumin with gentle rolling for 6 h at room temperature. The
eluted complexes were acetone-precipitated, dissolved in SDS sample
buffer, boiled, and loaded onto 4-15% SDS-PAGE gels. The wet gels
were exposed to film at 4 °C overnight, followed by immunoblotting
as described previously (26). After the initial DNA-binding reaction,
some of the samples were treated with 0.01% glutaraldehyde for 20 min in order to produce dimers and higher order NM23 oligomers (26) as
markers for migration.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
View larger version (11K):
[in a new window]
Fig. 1.
Sequence of DNA substrates used in these
studies. All c-MYC substrates were double-stranded and
comprised of the c-MYC NHE
150 to
115 relative to the P1
transcription initiation site. The 57-bp DNA fragment was prepared by
BamHI and EcoRI restriction of the pUC19myc
plasmid (see "Experimental Procedures"). The 45- and 34-bp DNA
substrates were synthetic oligonucleotides. All c-MYC
substrates contain two CCCACCC PuF/NM23-H2-binding sites (22), four to
five TCCCCA, and three to four CCTCCCCA directly repeated motifs.

View larger version (26K):
[in a new window]
Fig. 2.
DNA binding and cleavage by NM23-H2.
Reactions in lanes 1-3 and 6-7 contained 10 nM 34-bp c-MYC oligonucleotide and lanes
4 and 5 the same amount of nonspecific 34-mers.
Lane 2 reaction had 8 nM; lanes 3, 5, and 7 had 16 nM hexameric wild type NM23-H2; and
lane 6 had 16 nM R34A mutant protein.
MgCl2 was 2 mM in each reaction and KCl was 70 mM. Arrows on the side panel point to
positions of the complexed, free, and cleaved DNAs separated on 5%
native acrylamide gels.

View larger version (37K):
[in a new window]
Fig. 3.
Effect of metal ions, EDTA, and ATP on
cleavage of DNA by NM23-H2. A, all reactions contained
3'-end-labeled 57-bp DNA fragments (
1nM); lane
1 had no protein; lanes 2-4 had 2 nM
protein. MgCl2 concentrations (in mM) were as
shown above each lane, and KCl was 70 mM.
B, DNA was as in A, KCl concentrations as
indicated above lanes; NM23-H2 was 0.2, 0.5, 1, 2, 5, and 10 nM, respectively, and MgCl2 was 2 mM in each lane. C, reactions in lanes
1-5 had 3'-end-labeled and lanes 6-10 had
5'-end-labeled 57-bp DNA fragment. Lanes 1 and 6 had no protein; all others contained 2 nM NM23-H2.
MgCl2 was 2 mM, and KCl was 70 mM
in each reaction. To reactions in lanes 3 and 8 EDTA was added at the beginning, and to lanes 4 and
9 EDTA was added at the end followed by proteinase K
treatment. In lanes 5 and 10 1 mM ATP
was included in the reaction. Arrows point to the positions
of complexed, free, and cleaved DNA fragments. Note that both KCl (in
B) and EDTA (lanes 3, 4, 8, and 9 in
C) retard electrophoretic migration of the cleaved DNA
fragments.

View larger version (29K):
[in a new window]
Fig. 4.
Structure of the NM23-H2 cleavage site mapped
on uniquely end-labeled DNA fragments. A, cleavages on
the 57-bp 3'-end-labeled (TOP) and the 5'-end-labeled
(BOT) DNA fragments at the EcoRI restriction end.
Major and minor cleavage sites are marked with arrows on the
side panel; nt, lengths in nucleotides.
Lanes 1 and 4 contain G and C-specific sequencing
ladders (29). B, summary of cleavage sites deduced from six
independent experiments. Large arrows mark major cleavage
sites, and arrowheads point to minor cleavages. The affected
bases at the cleavage site are underlined.

View larger version (42K):
[in a new window]
Fig. 5.
Cleavage of negatively supercoiled plasmid
DNA by NM23-H2. A, reactions were assembled in 120 mM KCl, 1 mM MgCl2, 2.4 nM pUC19myc plasmid, and 0, 2.5, 5, 7.5, 10, and 15 nM NM23-H2 hexamers (lanes 1-6). Marker in
lane 7 is BamHI-linearized, and in lane
8, DNase I-nicked (28) plasmids. Gel was run at 100 V for 1.5 h in 0.5 × TBE, 0.1% SDS. B, Ten nM each
of wild type NM23-H2 (lanes 1 and 3-7), K135H mutant
(lane 8), and NM23-H1 proteins (lane 9) were
reacted with 2.4 nM pUC19myc plasmid. KCl was 120 mM and MgCl2 1 mM. Lane
4 had 10 mM EDTA at the start of the reaction, and in
lane 5 EDTA was added after the reaction, followed by
proteinase K treatment. Lane 6 had 1 mM ATP. In
lane 7 NM23-H2 was incubated overnight at 0 °C with
monoclonal antibody 3E4 (26) before plasmid was added. Gel was run at
100 V for 1.5 h in 0.5 × TAE buffer. Arrows on
side panels indicate plasmid states: SC,
supercoiled; Lin, linear; OC, open circle/nicked
circular. Species migrating behind the monomeric OC are supercoiled and
nicked dimers intrinsic to the plasmid preparations.
Asterisks mark high molecular weight DNA of unknown origin.
All lanes are from the same gel, although not necessarily
adjacent.
-32P]ATP (36) in order to mark its electrophoretic
migration. The slightly reduced mobility of the DNA-radiolabeled NM23
peptide (lane 3 versus 1) further
suggests that despite the extensive treatments nucleotide residues have
remained attached to it (37).

View larger version (32K):
[in a new window]
Fig. 6.
Covalent complex formation between NM23-H2
and DNA. A, transfer of 32P radioactivity
from plasmid to NM23-H2. Left panel shows photograph of
SDS-PAGE gel after Coomassie staining, and the right panel
shows autoradiogram of the dried gel. Lane 1 has pure
unreacted NM23-H2 without any DNA or treatment, except it was
autophosphorylated with [
-32P]ATP. Lane 2,
reaction without NM23; lane 3, result of NM23 incubation
with DNA; lane 4, same as lane 3 after
proteinase K digestion. Faint Coomassie-stained bands at ~34 kDa in
lanes 2 and 3 are DNase I used for plasmid
digestion. The strong band in lane 4 is proteinase K. Left lane shows molecular mass standards in kDa.
Arrow on the right points to the 17-kDa NM23-H2
peptide. B, complexes formed between NM23-H2 and
32P linear DNA fragments were first separated on native
acrylamide gels, purified, and then subjected to denaturing
electrophoresis in SDS-PAGE gels. Left panel is
autoradiogram of the wet gel; right panel shows the
immunoblot of the same gel. Reactions in lanes 2 and
4 contained, in addition to the 17-kDa NM23-H2 monomeric
peptide, dimers and higher order oligomers generated by glutaraldehyde
cross-linking (26). Left panel shows the molecular mass in
kDa of monomeric, DNA-complexed, and dimeric NM23-H2.

View larger version (19K):
[in a new window]
Fig. 7.
NM23-H2 binds to cleaved DNA at the
5'-phosphoryl end and has free 3'-hydroxyl groups. A,
reactions were assembled in 120 mM KCl as for mobility
shift assays (Fig. 3B) but were stopped with SDS, and in
lanes 3 and 6 were further treated with
proteinase K. Lanes 1 and 4 had no NM23-H2.
Reactions contained 120 mM KCl and were run in a 5%
sequencing gel. DNA substrate on the left panel was
5'-end-labeled and on the right panel was a 3'-end-labeled
57-bp fragment. B, procedures were as in A,
except the reactions contained 50 mM KCl and were run in an
8% sequencing gel. Note that the NM23-H2-cleaved fragment on the
3'-end is shorter than the fragment from the 5'-end (see Fig. 4).
C, labeling of the 3'-OH end of the NM23-H2 cleaved DNA strand with [
-32P]ddATP and terminal
deoxynucleotidyltransferase. Panel is an autoradiographic
exposure of the dried down gel. Arrows on the
left point to NM23-H2-cleaved and control
BamHI-digested linear DNA fragments. Both lanes
contained the same amount (50 ng) of DNA.
-32P]ddATP (Fig. 7C, lane 2).
By inference, therefore, protein attachment is at the 5'-end. The
control plasmid linearized with BamHI was also
32P-end-labeled, as was expected by virtue of its
containing 3'-OH groups, albeit recessed, at the end cleaved by
restriction enzyme (Fig. 7C, lane 1).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed. Tel.: 609-258-2816;
Fax: 609-258-1067/1701; E-mail: epostel@molbio.princeton.edu.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Steeg, P. S.,
Bevilacqua, G.,
Kopper, L.,
Thorgeirsson, U. P.,
Talmadge, J. E.,
Liotta, L. A.,
and Sobel, M. E.
(1988)
J. Natl. Cancer Inst.
80,
200-204 2.
Rosengard, A. M.,
Krutzsch, H. C.,
Shearn, A.,
Biggs, J. R.,
Barker, E.,
Margulies, I. M.,
King, C. R.,
Liotta, L. A.,
and Steeg, P. S.
(1989)
Nature
342,
177-180[CrossRef][Medline]
[Order article via Infotrieve]
3.
de la Rosa, A.,
Williams, R. L.,
and Steeg, P. S.
(1995)
BioEssays
17,
53-62[CrossRef][Medline]
[Order article via Infotrieve]
4.
Hailat, N.,
Keim, D. R.,
Melhem, R. F.,
Zhu, X. X.,
Eckerskorn, C.,
Brodeur, G. M.,
Reynolds, C. P.,
Seeger, R. C.,
Lottspeich, F.,
Strahler, J. R.,
and Hanash, S.
(1991)
J. Clin. Invest.
88,
341-245
5.
Martinez, J. A.,
Prevot, S.,
Nordlinger, B.,
Nguyen, T. M.,
Lacarriere, Y.,
Munier, A.,
Lascu, I.,
Vaillant, J. C.,
Capeau, J.,
and Lacombe, M. L.
(1995)
Gut
37,
712-720 6.
Zhang, L.,
Zhou, W.,
Velculescu, V. E.,
Kern, S. E.,
Hruban, R. H.,
Hamilton, S. R.,
Vogelstein, B.,
and Kinzler, K. W.
(1997)
Science
276,
1268-1272 7.
Shimada, N.,
Ishikawa, N.,
Munakata, Y.,
Toda, T.,
Watanabe, K.,
and Kimura, N.
(1993)
J. Biol. Chem.
268,
2583-2589 8.
Milon, L.,
Rousseau-Merck, M. F.,
Munier, A.,
Erent, M.,
Lascu, I.,
Capeau, J.,
and Lacombe, M. L.
(1997)
Hum. Genet.
99,
550-557[CrossRef][Medline]
[Order article via Infotrieve]
9.
Dearolf, C. R.,
Hersperger, E.,
and Shearn, A.
(1988)
Dev. Biol.
129,
159-168[CrossRef][Medline]
[Order article via Infotrieve]
10.
Lacombe, M. L.,
Wallet, V.,
Troll, H.,
and Veron, M.
(1990)
J. Biol. Chem.
265,
10012-10018 11.
Stahl, J. A.,
Leone, A.,
Rosengard, A. M.,
Porter, L.,
King, C. R.,
and Steeg, P. S.
(1991)
Cancer Res.
51,
445-449 12.
Venturelli, D.,
Martinez, R.,
Melotti, P.,
Casella, I.,
Peschle, C.,
Cucco, C.,
Spampinato, G.,
Darzynkiewicz, Z.,
and Calabretta, B.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
7435-7439 13.
Munier, A.,
Feral, C.,
Milon, L.,
Pinon, V. P.,
Gyapay, G.,
Capeau, J.,
Guellaen, G.,
and Lacombe, M. L.
(1998)
FEBS Lett.
434,
289-294[CrossRef][Medline]
[Order article via Infotrieve]
14.
Okabe-Kado, J.,
Kasukabe, T.,
Hozumi, M.,
Honma, Y.,
Kimura, N.,
Baba, H.,
Urano, T.,
and Shiku, H.
(1995)
FEBS Lett.
363,
311-315[CrossRef][Medline]
[Order article via Infotrieve]
15.
Howlett, A. R.,
Petersen, O. W.,
Steeg, P. S.,
and Bissell, M. J.
(1994)
J. Natl. Cancer Inst.
86,
1838-1844 16.
Ji, L.,
Arcinas, M.,
and Boxer, L. M.
(1995)
J. Biol. Chem.
270,
13392-13398 17.
Backer, J. M.,
Mendola, C. E.,
Kovesdi, I.,
Fairhurst, J. L.,
O'Hara, B.,
Eddy, R. L., Jr.,
Shows, T. B.,
Mathew, S.,
Murty, V. V.,
and Chaganti, R. S.
(1993)
Oncogene
8,
497-502[Medline]
[Order article via Infotrieve]
18.
Gilles, A. M.,
Presecan, E.,
Vonica, A.,
and Lascu, I.
(1991)
J. Biol. Chem.
266,
8784-8789 19.
Lascu, I.,
Morera, S.,
Chiadmi, M.,
Cherfils, J.,
Janin, J.,
and Veron, M.
(1996)
in
Techniques in Protein Chemistry
(Marshak, D. R., ed), Vol. VII
, pp. 209-217, Academic Press, San Diego
20.
Webb, P. A.,
Perisic, O.,
Mendola, C. E.,
Backer, J. M.,
and Williams, R. L.
(1995)
J. Mol. Biol.
251,
574-587[CrossRef][Medline]
[Order article via Infotrieve]
21.
Morera, S.,
Lacombe, M. L.,
Xu, Y.,
LeBras, G.,
and Janin, J.
(1995)
Structure
3,
1307-1314
22.
Postel, E. H.,
Mango, S. E.,
and Flint, S. J.
(1989)
Mol. Cell. Biol.
9,
5123-5133 23.
Postel, E. H.,
Berberich, S. J.,
Flint, S. J.,
and Ferrone, C. A.
(1993)
Science
261,
478-480 24.
Berberich, S. J.,
and Postel, E. H.
(1995)
Oncogene
10,
2343-2347[Medline]
[Order article via Infotrieve]
25.
Arcinas, M.,
and Boxer, L. M.
(1994)
Oncogene
9,
2699-2706[Medline]
[Order article via Infotrieve]
26.
Postel, E. H.,
Weiss, V. H.,
Beneken, J.,
and Kirtane, A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
6892-6897 27.
Yi, X.,
Sweitzer, N.,
and Otero, A.
(1996)
Biochim. Biophys. Acta
1310,
334-342[Medline]
[Order article via Infotrieve]
28.
Kanaar, R.,
Klippel, A.,
Shekhtman, E.,
Dungan, J. M.,
Kahmann, R.,
and Cozzarelli, N. R.
(1990)
Cell
62,
353-366[CrossRef][Medline]
[Order article via Infotrieve]
29.
Maxam, A. M.,
and Gilbert, W.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
560-564 30.
Liu, L.
(1994)
Adv. Pharmacol.
29,
1-315
31.
Champoux, J. J.
(1994)
Adv. Pharmacol.
29,
71-82
32.
Wang, J. C.
(1996)
Annu. Rev. Biochem.
65,
635-692[CrossRef][Medline]
[Order article via Infotrieve]
33.
Sadowski, P. D.
(1993)
FASEB J.
7,
760-767[Abstract]
34.
Stark, W. M.,
Boocock, M. R.,
and Sherratt, D. J.
(1992)
Trends Genet.
8,
432-439[Medline]
[Order article via Infotrieve]
35.
Jayaram, M.
(1994)
Trends Biochem. Sci.
19,
78-82[CrossRef][Medline]
[Order article via Infotrieve]
36.
Postel, E. H.,
and Ferrone, C. A.
(1994)
J. Biol. Chem.
269,
8627-8630 37.
Pargellis, C. A.,
Nunes-Duby, S. E.,
de Vargas, L. M.,
and Landy, A.
(1988)
J. Biol. Chem.
263,
7678-7685 38.
Xu, J.,
Liu, L. Z.,
Deng, X. F.,
Timmons, L.,
Hersperger, E.,
Steeg, P. S.,
Veron, M.,
and Shearn, A.
(1996)
Dev. Biol.
177,
544-557
39.
Postel, E. H.
(1998)
Int. J. Biochem. Cell Biol.
30,
1291-1295[CrossRef][Medline]
[Order article via Infotrieve]
40.
Bates, A.,
and Maxwell, A.
(1993)
DNA Topology
, Oxford University Press, New York
41.
Wigley, D.
(1995)
Annu. Rev. Biophys. Biomol. Struct.
24,
185-208[CrossRef][Medline]
[Order article via Infotrieve]
42.
Cherfils, J.,
Morera, S.,
Lascu, I.,
Veron, M.,
and Janin, J.
(1994)
Biochemistry
33,
9062-9069[CrossRef][Medline]
[Order article via Infotrieve]
43.
Kwon, H. J.,
Tirumalai, R.,
Landy, A.,
and Ellenberger, T.
(1997)
Science
276,
126-131 44.
Montecino, M.,
Lian, J.,
Stein, G.,
and Stein, J.
(1996)
Biochemistry
35,
5093-5102[CrossRef][Medline]
[Order article via Infotrieve]
45.
Malins, D. C.,
Polissar, N. L.,
and Gunselman, S. J.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
14047-14052 46.
Pinon, V. P. B.,
Millot, G.,
Munier, A.,
Vassy, J.,
Linares-Cruz, G.,
Capeau, J.,
Calvo, F.,
and Lacombe, M. L.
(1999)
Exp. Cell Res.
246,
355-367[CrossRef][Medline]
[Order article via Infotrieve]
47.
Kraeft, S. K.,
Traincart, F.,
Mesnildrey, S.,
Bourdais, J.,
Veron, M.,
and Chen, L. B.
(1996)
Exp. Cell Res.
227,
63-69[CrossRef][Medline]
[Order article via Infotrieve]
48.
Schwab, M.,
Praml, C.,
and Amler, L. C.
(1996)
Genes Chromosomes Cancer
16,
211-229[CrossRef][Medline]
[Order article via Infotrieve]
49.
Peukert, K.,
Staller, P.,
Schneider, A.,
Carmichael, G.,
Hanel, F.,
and Eilers, M.
(1997)
EMBO J.
16,
5672-5686[CrossRef][Medline]
[Order article via Infotrieve]
50.
Battey, J.,
Moulding, C.,
Taub, R.,
Murphy, W.,
Stewart, T.,
Potter, H.,
Lenoir, G.,
and Leder, P.
(1983)
Cell
34,
779-787[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. C. Goswami, J.-H. Yoon, B. M. Abramczyk, G. P. Pfeifer, and E. H. Postel Molecular and Functional Interactions between Escherichia coli Nucleoside-diphosphate Kinase and the Uracil-DNA Glycosylase Ung J. Biol. Chem., October 27, 2006; 281(43): 32131 - 32139. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Mechold, V. Ogryzko, S. Ngo, and A. Danchin Oligoribonuclease is a common downstream target of lithium-induced pAp accumulation in Escherichia coli and human cells. Nucleic Acids Res., January 1, 2006; 34(8): 2364 - 2373. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kumar, A. Verma, A. K. Saini, P. Chopra, P. K. Chakraborti, Y. Singh, and S. Chowdhury Nucleoside diphosphate kinase from Mycobacterium tuberculosis cleaves single strand DNA within the human c-myc promoter in an enzyme-catalyzed reaction Nucleic Acids Res., May 11, 2005; 33(8): 2707 - 2714. [Abstract] [Full Text] [PDF] |
||||